The QT interval is commonly monitored using an electrocardiogram (ECG). Baseline ECGs are often performed before starting a new cancer treatment known to affect the QT interval. Follow-up ECGs may be conducted regularly during treatment to monitor for changes. In some cases, continuous ECG monitoring might be recommended, especially for patients receiving high-risk treatments.